Does FUROSEMIDE\SPIRONOLACTONE Cause Urinary retention? 41 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 41 reports of Urinary retention have been filed in association with FUROSEMIDE\SPIRONOLACTONE. This represents 16.7% of all adverse event reports for FUROSEMIDE\SPIRONOLACTONE.
41
Reports of Urinary retention with FUROSEMIDE\SPIRONOLACTONE
16.7%
of all FUROSEMIDE\SPIRONOLACTONE reports
0
Deaths
41
Hospitalizations
How Dangerous Is Urinary retention From FUROSEMIDE\SPIRONOLACTONE?
Of the 41 reports, 41 (100.0%) required hospitalization.
Is Urinary retention Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FUROSEMIDE\SPIRONOLACTONE. However, 41 reports have been filed with the FAERS database.
What Other Side Effects Does FUROSEMIDE\SPIRONOLACTONE Cause?
Hyperkalaemia (82)
Syncope (62)
Acute kidney injury (53)
Dyspnoea (52)
Hyponatraemia (52)
General physical health deterioration (51)
Dyspepsia (50)
Eructation (47)
Joint dislocation (46)
Mitral valve incompetence (46)
What Other Drugs Cause Urinary retention?
MIRABEGRON (706)
QUETIAPINE (617)
TAMSULOSIN (475)
ADALIMUMAB (452)
MORPHINE (407)
OLANZAPINE (405)
SERTRALINE (380)
PREGABALIN (376)
RISPERIDONE (375)
DULOXETINE (362)
Which FUROSEMIDE\SPIRONOLACTONE Alternatives Have Lower Urinary retention Risk?
FUROSEMIDE\SPIRONOLACTONE vs FUSIDATE
FUROSEMIDE\SPIRONOLACTONE vs FUSIDIC ACID
FUROSEMIDE\SPIRONOLACTONE vs FUTIBATINIB
FUROSEMIDE\SPIRONOLACTONE vs GABAPENTIN
FUROSEMIDE\SPIRONOLACTONE vs GABAPENTIN ENACARBIL